Roughly 80% of people with myotonic dystrophy—a common form of
Discovery points to innovative new way to treat Duchenne muscular dystrophy
Researchers at The Ottawa Hospital and the University of Ottawa
New mouse model may speed identification of promising muscular dystrophy therapies
A Massachusetts General Hospital (MGH) research team has created a
A role for Scn5a missplicing in cardiac arrhythmias in myotonic dystrophy
A team of researchers at Baylor College of Medicine reveals
Extracellular RNA in urine may provide useful biomarkers for muscular dystrophy
Massachusetts General Hospital (MGH) researchers have found that extracellular RNA
Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy
August 30, 2018 – Pfizer Inc. (NYSE: PFE) announced today